Teva - Out Values Our Strength Middle Manager Program

By Rachel Batykefer, Associate Director Global Compliance, Teva 2019-01-15T14:24:31.253+00:00

Topics

Article
FTC gearing up for aggressive oversight of antitrust, M&A
2021-04-13T20:05:00Z
With a changing of the guard, the Federal Trade Commission is undergoing some major restructuring on the antitrust front. All told, it’s not just Big Tech and pharmaceutical companies that should be on alert.
Article
Archegos collapse: $20 billion in losses, but a win for compliance
2021-04-12T12:45:00Z
The collapse of Archegos Capital Management may go down as yet another episode that champions the importance of the voice of the compliance professional, writes Martin Woods.
Article
Compliance lessons, regulatory fallout from Archegos meltdown
2021-04-12T12:45:00Z
There are plenty of unanswered questions following the recent meltdown of family office Archegos Capital Management—and plenty of compliance lessons to be learned, writes Aaron Nicodemus.

You're not signed in.